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INTRODUCTION
Acute eosinophilic pneumonia (AEP) is characterized by an
acute febrile onset, progressive respiratory failure, bilateral
chest infiltrates, an increase of eosinophils in bronchoalveolar
lavage fluid (>25%), and a dramatic response to corticosteroids.
It was first described by Allen and colleagues in 1989 (1),
but the cause remains unknown. Some investigators suggest
that unidentified inhaled antigens, such as Aspergillus species,
mycotic infections, parasite infestations, drugs, and chemi-
cal agents, may induce a hypersensitivity reaction in an oth-
erwise healthy individual (2).
The smoking of cigarettes has been proposed as a cause of
AEP (3-5). Most of the papers published have described young
Asians with episodic events, who started smoking prior to
the time symptoms developed. We present a case of a young
Korean patient, suspected to have cigarette smoking-induced
AEP who was treated with corticosteroids and later showed
recurrent symptoms on a provocation test. 
CASE REPORT
An 18-yr-old Asian male presented to our department com-
plaining of dyspnea on exertion and fever for over 24 hr. He
denied chest pain, hemoptysis, or cough. He reported no
family or past medical history and denied the use of drugs
or medication. He denied any history of allergic conditions.
He reported starting smoking up to 1 pack per day approx-
imately 30 days prior to the admission. On examination, his
body temperature was 38.5℃. The findings of complete
blood cell counts revealed a white blood cell count of 27,800/
L with segmented neutrophils at 94%. Arterial blood gas
analysis showed pH of 7.424, PaO2 of 66.2 mmHg, and PCO2
of 38.0 mmHg in room air. Inspiratory rhonchi and wheez-
ing were heard on both lower lung fields on auscultation.
Chest radiography showed multi-focal opacities in both lungs
(Fig. 1). Blood and sputum cultures were taken, and antibi-
otics were promptly administered under the impression of
bacterial pneumonia. Despite antibiotic therapy with moxi-
floxacin and clarithromycin, clinical and laboratory parame-
ters did not improve. On the 3rd day of hospital admission,
dyspnea worsened and he developed peripheral cyanosis. He
also developed a productive cough. Expectorated sputum was
mucoid with a whitish to yellowish appearance. Documented
fever persisted, from 38 up to 39℃. Serial chest radiographs
also showed aggravation (Fig. 1). Cultures from blood, sputum,
and urine were negative, and serologic tests for Mycoplasma
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Cigarette Smoking-Induced Acute Eosinophilic Pneumonia: A Case
Report Including a Provocation Test
The mechanism and cause of acute eosinophilic pneumonia are largely unknown.
Many factors including the smoking of cigarettes have been suggested, but none
have been proven to directly cause acute eosinophilic pneumonia. The authors
report a case of acute eosinophilic pneumonia in a young Asian male who recently
started smoking. The diagnosis was made based on his clinical course and results
of chest radiography, lung spirometry, bronchoalveolar lavage, and transbronchial
lung biopsies. After administration of methylprednisolone, his clinical course rapidly
improved. A provocation test was designed to establish a connection between cigarette
smoking and the development of acute eosinophilic pneumonia. After the provo-
cation test, the patient showed identical symptoms, increase in sputum eosinophils,
and worsening of pulmonary function. The results of the provocation test suggest
that smoking may directly cause acute eosinophilic pneumonia, and support previ-
ous reports of cigarette smoking-induced acute eosinophilic pneumonia.
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pneumoniae, Legionella pneumophila, Streptococcus pneumoniae, para-
sites (Taenia solium, Paragonomus westermani, Spirometra, Clo-
norchis sinensis), and viral tests including human immunodefi-
ciency virus were also negative. Serologic markers for autoim-
mune diseases including immunoglobulin, complements
and autoimmune antibodies were non-specific. High reso-
lution computed tomography of the chest showed diffuse
nonsegmental patchy or nodular ground glass attenuation
in both lungs, small air space consolidations in the periph-
eral portion of both upper lungs, and diffuse interlobular
septae thickening. On lung spirometry forced vital capacity
(FVC), forced expiratory volume of 1 sec (FEV1) and their
ratio (FEV1/FVC) were 65%, 54%, and 76% of predicted
value, respectively. Diffusion of carbon monoxide (DLco) was
58% of predicted value.
Bronchoalveolar lavage (BAL) and transbronchial lung
biopsies were performed on the 4th day of admission to clar-
ify the pulmonary process. Analysis of BAL fluids showed a
significant increase in eosinophils, 39%. Transbronchial lung
biopsies revealed mild interstitial thickening with significant
eosinophil infiltration (Fig. 3). The patient met the criteria
for AEP described by Allen and Davis (2). Clinical symptoms
rapidly subsided after administration of intravenous methyl-
prednisolone (125 mg/day), and C-reactive protein and spu-
tum eosinophil levels as well as follow-up chest radiology show-
ed rapid improvement (Fig. 1). To identify the cause of AEP,
we carefully reviewed the history of the patient. The only
significant change in his life style or environment was the
recent beginning of smoking 1 month before. To establish a
connection between smoking and the development of AEP,
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Fig. 1. The time axis of sputum eosinophil percentage, absolute
eosionphil count per microliter, chest radiograph, and high reso-
lution computed tomography findings. Administration of 125 mg/
day of methylprednisolone is shown by short arrows. The cigarette
smoking challenge test is shown by the long arrow. Multifocal
patchy infiltrates and interlobular septae thickening can be seen
on chest radiography and high-resolution computed tomography.
After administration of methlyprednisolone, the infiltrates and ele-
vated sputum eosinophil percentage rapidly resolved. After the
cigarette smoking challenge test, a sharp increase of in sputum eo-
sinophils was observed, but there were no recurrent findings of lung
infiltrates on chest radiography. 
Fig. 2. The cigarette smoking challenge test and changes in body
temperature, forced vital capacity (FVC), forced expiratory volume
of 1 sec (FEV1), and diffusion of carbon monoxide (DLco) with
respect to the elapsed time after smoking. Approximately 3 hr
after smoking, a moderate decrease in DLco and mild decrease
in FVC and FEV1 were observed. Body temperature reached its
peak 6 hr after the first cigarette smoking.
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Fig. 3. Transbronchial lung biopsy showing marked infiltration of
eosinophils and interstitial thickening. Eosinophils are shown by
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we decided to perform a provocation test with given inform-
ed consent. He was given 1 cigarette to smoke, followed by
an additional 3 cigarettes 2 hr later. Before and after smok-
ing, his vital signs, sputum eosinophil percentage, C-reac-
tive protein, white blood cells with % of eosinophils from
peripheral blood, partial oxygen pressure, spirometry, and
DLCO were checked regularly. The same laboratory and lung
function parameters were followed up serially when the pati-
ent perceived any changes in his condition. Two hours after
the last cigarette smoking, a mild fever at 37.6℃ developed.
High fever and chills developed 7 hr later. Cough and spu-
tum redeveloped the following day. An increase in self expec-
torated sputum eosinophils and decrease in FEV1 and DLCO
(Fig. 2) were observed. Fever and other symptoms were reliev-
ed by methylprednisolone. 
DISCUSSION
The diagnostic criteria for AEP was suggested by Allen
and Davis (2), which include an acute febrile illness of short
duration (usually less than one week), hypoxemic respirato-
ry failure, diffuse pulmonary opacities on chest radiograph,
BAL eosinophilia >25 percent, evidence of eosinophilic infil-
trates (acute and organizing diffuse alveolar damage with
prominent eosinophilia)  on lung biopsy, and absence of known
causes of eosinophilic pneumonia, including drugs, infec-
tions, asthma, or atopic disease. Some authors suggest that
the diagnosis can be made with confidence without lung
biopsy in immunocompetent patients with a compatible
history and prominent BAL eosinophilia in the absence of
infection or other know precipitants (6). The patient in our
case met the criteria, and we were able to make the diagno-
sis of AEP without a difficulty. However, we were not cer-
tain whether smoking played a role in the development of
AEP. This led us to design a provocation test. 
Since 1996, there have been several reports of cigarette smok-
ing-induced AEP. Some investigators have tried a cigarette
smoking challenge test to provoke recurrence in patients who
recovered from AEP (3). The cigarette smoking challenge
test that we designed was similar, but the test was performed
almost immediately after the patient showed full recovery.
We demonstrated that not only sputum eosinophilia but the
symptoms of AEP and worsening of pulmonary function
could be reproduced by a provocation test. The patient’s symp-
toms after the provocation test were mild, but almost iden-
tical to those at admission. Worsening of pulmonary func-
tion, particularly DLCO, and the increase in self expectorated
sputum eosinophils were also characteristic. Moreover, symp-
toms and pulmonary function normalized almost immedi-
ately after readministration of steroids. Although symptoms
fully recovered, peripheral eosinophil counts were beginning
to climb at the time we decided to perform the provocation
test. However, the absence of peripheral eosinophilia in the
acute stages of AEP with elevation during recovery is a fea-
ture of AEP that has been reported in several studies (7-10).
Because peripheral eosinophilia was also absent in the acute
stages of disease and appeared after the patient had shown
recovery, we decided to perform the test. Additionally, we
could find no previous reports of febrile episodes following
provocation at the time of recovery when peripheral eosinophil-
ia was evident (3, 10). 
Despite his recurrent symptoms, we could not find signif-
icant chest radiographic changes following the provocation
test. Generally, the early radiographic findings of AEP are
faint reticular markings that represent interstitial infiltra-
tion. As the disease progresses and/or the patient is exposed
to continuous stimuli, diffuse interstitial and patchy alveo-
lar infiltrates develop (8). We can only speculate that although
the single stimulus of the provocation test was enough to
induce a decrease in DLco and an inflammatory febrile res-
ponse, it may not have been sufficient enough to induce chest
radiographic changes. To our knowledge, there have been
no reports of chest radiographic change after a provocation
test in patients with AEP in the literature written in English.
After discharge, the patient restarted cigarette smoking,
but showed no evidence of recurrence for more than 1 yr of
follow-up. This may be explained by the development of
tolerance. There have been several reports of tolerance follow-
ing resumption of smoking cigarettes, but the mechanism
remains unknown (4). Shintani et al. speculated that desen-
sitization to cigarette smoke or interaction of various drugs
and viruses with cigarette smoke may play a role in the devel-
opment of tolerance (4). Indeed, though several investiga-
tors designed provocation tests to verify smoking-induced
AEP, tests that were not associated with recurrent symptoms
after provocation were performed 10-30 days after recovery
(3, 10). Considering this, the performance of the provoca-
tion test immediately after the patient’s recovery and associ-
ated recurrent symptoms may suggest that tolerance devel-
ops earlier than we expected.
To date, the cause or mechanism of AEP is not completely
understood, and no single organism or agent has been prov-
ed to directly cause AEP. Some patients have been involved
in unusual outdoor activities just prior to the onset of their
illness (6, 7, 11, 12). The possible role of environmental fac-
tors at home has also been suggested (13). High levels of inter-
leukin-5 have been found in the BAL fluid (14-16) suggest-
ing its pathogenic role in AEP. In addition, interleukin-1
receptor antagonist, soluble type II interleukin-1 receptor,
vascular endothelial growth factor, and granulocyte macro-
phage colony stimulating factor have also been found in the
BAL fluid of patients with AEP, but their roles in the patho-
genesis of AEP remain unknown (16, 17).
The cause of AEP is unknown and cigarette smoking may
represent only one of many associated factors. However, the
recurrence of eosinophlic pneumonia by provocation test
supports previous reports that in certain individuals cigaretteSmoking-Induced AEP Including a Provocation Test 137
smoking may induce AEP. Further studies and understand-
ing of the mechanism of AEP are needed to reach a conclu-
sion, and the use of provocation tests such as the one used in
our case may shed a light on this subject. The majority of
reported cigarette smoking-induced AEP cases are young
adults who were first-time smokers. In light of these reports
and considering the increase of early cigarette smoking in
young adults, it is important that physicians are aware of
the possibility of this potentially life-threatening, but fully
reversible disease.
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